SINOVA-M-14021 β-Human Chorionic Gonadotropin (β-HCG) Quantitative Test Kit
Clinical Significance: HCG testing is crucial for the early diagnosis of pregnancy and has diagnostic, differential, and monitoring value for pregnancy-related diseases, trophoblastic tumors, and other conditions.
- Early Pregnancy Diagnosis: HCG levels can rise above 2500 mIU/mL 35-50 days after conception and reach up to 80000 mIU/mL by 60-70 days. In cases of multiple pregnancies, urinary HCG levels are often higher than in single pregnancies.
- Assessment of Abnormal Pregnancy and Placental Function.
- Diagnosis and Monitoring of Trophoblastic Tumors.
- Other Conditions: Menopause, ovulation, and bilateral oophorectomy can elevate luteinizing hormone (LH) levels, leading to positive pregnancy tests using anti-HCG antibodies due to the identical α-peptide chain composition of LH and HCG. Monoclonal β-HCG enzyme immunoassays can differentiate in such cases. HCG levels may also be elevated in endocrine diseases like pituitary disorders, hyperthyroidism, and gynecological conditions such as ovarian cysts and uterine cancer.
Product Specifications: 20 tests/box
Product Shelf Life: 18 months when sealed in an aluminum foil pouch. Use within 1 hour after opening the pouch.
Product Storage: Store the test card at 2℃-30℃.
Usage Scenarios:
- Hospitals and Clinics: For early pregnancy diagnosis, assessment of abnormal pregnancy and placental function, and diagnosis and monitoring of trophoblastic tumors.
- Fertility Centers: To monitor ovulation and diagnose pregnancy-related conditions.
- Diagnostic Laboratories: For routine pregnancy testing and differential diagnosis of conditions with elevated HCG levels.
Suitable Countries and Regions:
- Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc.
- Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc.
- Global Health Programs: International health initiatives focused on improving maternal health and pregnancy diagnostics in low-resource settings.

